Renal Cell Carcinoma 2012
DOI: 10.1007/978-1-62703-062-5_15
|View full text |Cite
|
Sign up to set email alerts
|

Integration of Surgery in Metastatic Renal Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 127 publications
0
1
0
Order By: Relevance
“…158,168 Evidence to help support the use of pre-surgical therapy was demonstrated in a phase II pre-surgical study that examined the role of bevacizumab. The authors found a median progression-free survival of 11 months and a median overall survival of 25.4 months.…”
Section: Role Of Pre-surgical Therapy In Advanced Kidney Cancermentioning
confidence: 40%
“…158,168 Evidence to help support the use of pre-surgical therapy was demonstrated in a phase II pre-surgical study that examined the role of bevacizumab. The authors found a median progression-free survival of 11 months and a median overall survival of 25.4 months.…”
Section: Role Of Pre-surgical Therapy In Advanced Kidney Cancermentioning
confidence: 40%